Role of survivin and its splice variants in tumorigenesis

British Journal of Cancer

Volumn 92, Issue 2, 2005, Pages 212-216

  Li, F ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Survivin; Survivin Ex3; Survivin 2B; Tumorigenesis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INHIBITOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ISOPROTEIN; MESSENGER RNA; RESVERATROL; RETINOIC ACID; SULINDAC; SURVIVIN;

CANCER GROWTH; CARCINOGENESIS; COLON CARCINOGENESIS; COLORECTAL CANCER; GENE MUTATION; HUMAN; LIVER CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA SPLICING; SHORT SURVEY; SKIN CARCINOGENESIS; SOFT TISSUE SARCOMA; STOMACH CANCER;

ANIMALS; APOPTOSIS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; RECOMBINATION, GENETIC;

EID: 14844313647     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602340     Document Type: Short Survey

References (38)

1. Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D (2003) Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res 63: 567-572
2. Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T, Inuzuka M (2004) Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun 314: 902-907
3. Cervello M, Giannitrapani L, La Rosa M, Notarbartolo M, Labbozzetta M, Poma P, Montalto G, D'Alessandro N (2004) Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation. Int J Mol Med 13: 741-748
4. Chen WC, Liu Q, Fu JX, Kang SY (2004) Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 10: 2886-2889
5. Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T, Shroyer KR (2002) Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 117: 738-744
6. Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79: 1121-1126
7. Hayashibara T, Yamada Y, Nakayama S, Harasawa H, Tsuruda K, Sugahara K, Miyanishi T, Kamihira S, Tomonaga M, Maita T (2002) Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: A prospective agent for adult T cell leukemia chemotherapy. Nutr Cancer 44: 193-201
8. Islam A, Kageyama H, Hashizume K, Kaneko Y, Nakagawara A (2000) Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 35: 550-553
9. Kappler M, Kohler T, Kampf C, Diestelkotter P, Wurl P, Schmitz M, Bartel F, Lautenschlager C, Rieber EP, Schmidt H, Bache M, Taubert H, Meye A (2001) Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 95: 360-363
10. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58: 5071-5074
11. Kawasaki H, Toyoda M, Shinohara H, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Tenjo T, Tanigawa N (2001) Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91: 2026-2032
12. Kim HS, Shiraki K, Park SH (2002) Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 22: 805-808
13. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC (2003) Survivin and molecular pathogenesis of colorectal cancer. Lancet 362: 205-209
14. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD (2002) Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer 86: 737-743
15. Li F (2003) Survivin study: what is the next wave? J Cell Physiol 197: 8-29
16. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T (2003) Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol 9: 974-977
17. Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, Pannone G, De Rosa G, Di Liberto C, D'Angelo M (2004) HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 40: 736-741
18. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T, Altieri DC (2003) Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82: 923-928
19. Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD (2002a) Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 100: 30-36
20. Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD (2002b) Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9: 1334-1342
21. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD (1999) Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-6102
22. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22: 2729-2740
23. Meng H, Lu CD, Sun YL, Dai DJ, Lee SW, Tanigawa N (2004) Expression level of wild-type survivin in gastric cancer is an independent predictor of survival. World J Gastroenterol 10: 3245-3250
24. Mori N, Yamada Y, Hata T, Ikeda S, Yamasaki Y, Tomonaga M, Yamamoto N (2001) Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. Biochem Biophys Res Commun 282: 1110-1113
25. Nakagawa Y, Yamaguchi S, Hasegawa M, Nemoto T, Inoue M, Suzuki K, Hirokawa K, Kitagawa M (2004) Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Leuk Res 28: 487-494
26. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD (2000) Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res 60: 4289-4298
27. Punga T, Akusjarvi G (2003) Adenovirus 2 E1B-55K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters. FEBS Lett 552: 214-218
28. Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C (2002) Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J 21: 2602-2615
29. Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, Tsuji M, Kami K, Miyatake S (2003) Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 99: 738-745
30. You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, Mikami I, Reguart N, McIntosh JK, Kashani-Sabet M, McCormick F, Jablons DM (2004a) An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 64: 5385-5389
31. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM (2004b) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170-6174
32. Zhang SQ, Qiang SY, Yang WB, Jiang JT, Ji ZZ (2004a) Expression of survivin in different stages of carcinogenesis and progression of breast cancer. Ai Zheng 23: 697-700
33. Zhang T, Fields JZ, Ehrlich SM, Boman BM (2004b) The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells. J Pharmacol Exp Ther 308: 434-437
34. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667
35. Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D (2004c) UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis (Epub ahead of print)
36. Zhao H, Granberg F, Elfineh L, Pettersson U, Svensson C (2003) Strategic attack on host cell gene expression during adenovirus infection. J Virol 77: 11006-11015
37. Zhu N, Gu L, Findley HW, Li F, Zhou M (2004) An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Oncogene 23: 7545-7551
38. Zhu Y, Roshal M, Li F, Blackett J, Planelles V (2003) Upregulation of survivin by HIV-1 Vpr. Apoptosis 8: 71-79